Journal of Andrology Download to Citation Manager
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Published-Ahead-of-Print April 4, 2007, DOI:10.2164/jandrol.107.002675
Journal of Andrology, Vol. 28, No. 5, September/October 2007
Copyright © American Society of Andrology
DOI: 10.2164/jandrol.107.002675

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
28/5/670    most recent
Author Manuscript (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Iguchi, K.
Right arrow Articles by Hirano, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Iguchi, K.
Right arrow Articles by Hirano, K.

Isolation and Characterization of LNCaP Sublines Differing in Hormone Sensitivity

KAZUHIRO IGUCHI*,{ddagger}, KENICHIRO ISHII{dagger},{ddagger}, TORU NAKANO*, TAKASHI OTSUKA*, SHIGEYUKI USUI*, YOSHIKI SUGIMURA{dagger} AND KAZUYUKI HIRANO*

From the * Laboratory of Pharmaceutics, Gifu Pharmaceutical University, Gifu, Japan; and {dagger} Department of Nephro-Urologic Surgery and Andrology, Mie University Graduate School of Medicine, Tsu, Mie, Japan.

Correspondence to: Dr Kazuyuki Hirano, Laboratory of Pharmaceutics, Gifu Pharmaceutical University, 5-6-1 Mitahora-higashi, Gifu 502-8585, Japan (e-mail: hirano{at}gifu-pu.ac.jp)..


Prostate cancer is a heterogeneous disease with varying degrees of androgen sensitivity. In this study, we performed a limiting dilution of human prostate LNCaP cells, and isolated two sublines, LNCaP-E9 and LNCaP-G4, with differential hormone-sensitivity. Two LNCaP sublines were obtained by the limiting dilution method. The growth of E9 cells was decreased in the presence of androgens, while that of androgen-treated G4 cells was biphasic. Although the androgen receptor expression level in E9 cells was similar to that seen in G4 cells, the expression of PSA mRNA and protein was significantly lower in the E9 cells. Moreover, the androgen-based stimulation of PSA mRNA expression was less sensitive in E9 cells than G4 cells. Intracellular zinc level did not differ between E9 and G4 cells, but ZnT3 mRNA expression was significantly higher in the E9 cells. When the cells were grafted at the subrenal capsule, the number of CD31-positive vessels with a lumen was approximately 2.5 times higher than that in G4 tumors. LNCaP-E9 cells show lower androgen sensitivity than LNCaP-G4 cells. E9 and G4 cells would be helpful for understanding the biology of hormone-refractory prostate cancer.

     Key words: Androgen sensitivity, PSA, limiting dilution




This article has been cited by other articles:


Home page
CarcinogenesisHome page
N. Dubi, L. Gheber, D. Fishman, I. Sekler, and M. Hershfinkel
Extracellular zinc and zinc-citrate, acting through a putative zinc-sensing receptor, regulate growth and survival of prostate cancer cells
Carcinogenesis, September 1, 2008; 29(9): 1692 - 1700.
[Abstract] [Full Text] [PDF]


Home page
J AndrolHome page
K. Iguchi, M. Ito, S. Usui, A. Mizokami, M. Namiki, and K. Hirano
Downregulation of Thymosin {beta}4 Expression by Androgen in Prostate Cancer LNCaP Cells
J Androl, March 1, 2008; 29(2): 207 - 212.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by The American Society of Andrology.